Monitoring Adverse Events Through Bayesian Nonparametric Clustering Across Studies
By: Shijie Yuan , Kevin Roberts , Noirrit Kiran Chandra and more
Potential Business Impact:
Finds hidden drug dangers faster and safer.
We introduce a Bayesian nonparametric inference approach for aggregate adverse event (AE) monitoring across studies. The proposed model seamlessly integrates external data from historical trials to define a relevant background rate and accommodates varying levels of covariate granularity (ranging from patient-level details to study-level aggregated summary data). Inference is based on a covariate-dependent product partition model (PPMx). A central element of the model is the ability to group experimental units with similar profiles. We introduce a pairwise similarity measure, with which we set up a random partition of experimental units with comparable covariate profiles, thereby improving the precision of AE rate estimation. Importantly, the proposed framework supports real-time safety monitoring under blinding with a seamless transition to unblinded analyses when indicated. Using one case study and simulation studies, we demonstrate the model's ability to detect safety signals and assess risk under diverse trial scenarios.
Similar Papers
A Nonparametric Bayesian Local-Global Model for Enhanced Adverse Event Signal Detection in Spontaneous Reporting System Data
Methodology
Finds rare drug side effects faster.
Knowledge-based Graphical Method for Safety Signal Detection in Clinical Trials
Computation and Language
Finds drug side effects faster and more clearly.
A General Bayesian Nonparametric Approach for Estimating Population-Level and Conditional Causal Effects
Methodology
Finds true cause of effects from messy data.